Dutton J J
Department of Ophthalmology, Duke University Eye Center, Durham, NC 27710.
Ophthalmology. 1991 Mar;98(3):370-7. doi: 10.1016/s0161-6420(91)32304-2.
Fifty patients received a coralline hydroxyapatite sphere as a buried integrated ocular implant after enucleation or evisceration surgery. The surgical technique is described and the results discussed. All patients obtained final prosthetic motility superior to that possible with simple spherical methylmethacrylate implants. After a follow-up of 2 to 27 months (mean, 10.4 months) there have been no cases of migration or extrusion. Complications have been minimal and easily managed. The hydroxyapatite implant appears to offer excellent cosmetic reconstruction without the unacceptable infection and extrusion rates seen with other integrated implants.
50例患者在眼球摘除术或眼内容剜出术后接受了珊瑚羟基磷灰石球作为埋藏式一体化眼内植入物。描述了手术技术并讨论了结果。所有患者最终获得的假体活动度均优于单纯球形甲基丙烯酸甲酯植入物所能达到的效果。在随访2至27个月(平均10.4个月)后,未出现迁移或挤出病例。并发症极少且易于处理。羟基磷灰石植入物似乎能提供出色的美容重建效果,而不会出现其他一体化植入物所存在的难以接受的感染和挤出率。